Tara Borntreger

Tara Borntreger serves as a key procurement professional within the Army Medical Resources Acquisition Activity, supporting the Defense Health Agency’s mission to enhance military medical readiness through advanced biomedical acquisition. She manages complex contracts for cutting-edge research, diagnostic systems, and life sciences technologies critical to sustaining the operational health of U.S. Army personnel. Her portfolio centers on high-performance analytical instrumentation, clinical diagnostics, and scientific consulting services, ensuring the integration of innovative medical capabilities into field-ready platforms. Borntreger’s work directly enables the agency’s strategic priorities in biomedical innovation and laboratory modernization, requiring deep technical understanding of life sciences procurement frameworks. She maintains consistent working relationships with a select group of specialized contractors, including CHENEGA Professional & Technical Services LLC, SNA International LLC, and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., all of which provide high-value scientific, technical, and biomedical support services. Her partnerships extend to international entities such as MABEAL GmbH and Canon Medical Informatics Inc., reflecting a global approach to sourcing advanced medical technologies. These collaborations are characterized by long-term, performance-based engagements focused on R&D, system integration, and operational readiness support. Borntreger’s contracting patterns reflect a strong preference for open, competed acquisitions, with 77.8% of awards issued without set-aside restrictions. However, she actively supports socioeconomic diversity through 8(a) competed contracts, which account for 22.2% of her portfolio, demonstrating a balanced commitment to both mission-critical efficiency and small business inclusion. Her primary procurement focus lies in NAICS 541714 (Research and Development in Biotechnology), which drives over 60% of her activity, followed by 541715 (Life Sciences R&D) and 541690 (Scientific Consulting). She routinely acquires specialized services in molecular diagnostics, clinical trial support, laboratory automation, and biomedical data analytics, underscoring her expertise in the intersection of military medicine and advanced life sciences innovation.